Prosecution Insights
Last updated: April 19, 2026

Hanmi Pharm. Co., Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17415474 PHARMACEUTICAL COMPOSITION INCLUDING INSULIN AND GLUCAGON BRADLEY, CHRISTINA 1654 Final Rejection Jun 17, 2021
17414682 THERAPEUTIC USE OF TRIGONAL GLUCAGON/GLP-1/GIP RECEPTOR AGONIST OR CONJUGATE THEREOF FOR LIVER DISEASE BUNNER, BRIDGET E 1647 Final Rejection Jun 16, 2021

Managing Hanmi Pharm. Co., Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month